GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Neoplasm Metastasis
Interventions: DRUG: Vorinostat|DRUG: Lapatinib
Sponsor: University of Maryland, Baltimore
Collaborators: University of Maryland Greenebaum Cancer Center